The International Task Force on Canine Atopic Dermatitis has published new, evidence-based guidelines for diagnosing, grading and treating Canine Atopic Dermatitis (AD).
Recently published in Veterinary Dermatology, the series of guidelines for general practitioners covers all aspects of the disease, including the recent rise in food allergy-related cases, and offers practical guidance for vets in diagnosing and grading the severity of AD.
The report also reviews the most appropriate treatment options for acute and chronic forms of the disease, and has awarded Cortavance (hydrocortisone aceponate) the best strength of evidence mark of any current treatment available.
Virbac technical director Chris Taylor MRCVS says the paper shows that Cortavance is now the benchmark for Atopic Dermatitis: "Not only do the guidelines confirm evidence of treatment success with Cortavance, but they also highlight that the skin-specific steroid spray has been shown to have no systemic effects, even when applied to one-third of the dog on a daily basis."
Chris also highlights the cost-effectiveness of Cortavance: "Some AD treatments can cost clients more than £2 per day, but with Cortavance owners are usually looking at costs of just pence per day.
"This report shows that not only is Cortavance the most effective treatment with a high safety margin, it is also surprisingly inexpensive too. And of course this should also help with compliance, particularly in uninsured animals."
The guidelines can be viewed or downloaded online free at: http://onlinelibrary.wiley.com/doi/10.1111/j.1365.3164.2010.00889.x/pdf
Companion Care Vets has announced it will work in partnership with VetAbroad, an e-learning company that has been established to help vets who qualified outside the UK to develop a successful career within it.
Companion Care is the first veterinary group in the UK to enter into partnership with VetAbroad, with the aim that all new non-UK employees will complete the course.
According to the company, almost 30% of vets registered in the UK are from overseas and statistics show that one in three will leave the register in less than 24 months and 20% in less than 12 months. Statistics also highlight the likelihood of a non-UK vet to be struck off or suspended is six times higher than for a UK vet.
Jane Balmain, Managing Director of Companion Care Vets said: "Whilst we as a company offer as much support as possible to our team members from overseas and support their continued learning , we are delighted to be working in partnership with VetAbroad to utilise their training solutions and further enhance what we offer to team members who come from overseas. All new employees will be required to take the course and we will also be encouraging our current overseas vets to complete it."
The e-course covers social and professional adaptation, compliance with current legislation, teamwork, productivity, client care and communication skills and VetAbroad states that those taking the course will substantially increase their chances of retaining and obtaining a job in the UK.
Vet and founder of VetAbroad Luis Sainz-Pardos said: "The primary aim of our course is to help vets who have qualified overseas to swiftly integrate into the UK system. Vets who have taken the course will be aware of UK legislation and should be able to interact with colleagues, clients and patients to a UK standard. As a result, the problems often associated with employing non-UK vets to work in UK practices are greatly reduced. I am thrilled to be working in partnership with Companion Care Vets, a company that I believe is thriving due to its investment in its most important asset - people."
For further information about VetAbroad please visit www.vetabroad.com
The BSAVA has announced the publication of its latest practical guide: The BSAVA Manual of Canine and Feline Abdominal Surgery.
The new manual covers everything from routine ovariohysterectomy to emergency drainage for acute peritonitis and features two new chapters on laparoscopic instrumentation/surgery and urinary incontinence.
The extensively revised and updated second edition equips veterinary surgeons with practical information, illustrations and images, along with step-by-step operative techniques that provide information on patient positioning and preparation, instrumentation and postoperative management for a variety of procedures.
International expertise includes editors John Williams and Jacqui Niles, as well as contributions from vets around the world.
The BSAVA says that hundreds of veterinary surgeons registered interest in advance after the first edition went out of print last year (2014) and a preview copy was made available at the BSAVA Congress in April.
John Williams said: "The BSAVA exists to promote excellence in small animal practice through education and science, and the BSAVA Manuals are instrumental in fulfilling this aim. As editors of this latest edition, Jacqui and I have had the privilege of being able to work with experts in their respective fields, to produce a practical guide packed full of the latest developments in abdominal surgical techniques that will be useful to the whole veterinary profession."
You can now buy a copy from the BSAVA website: www.bsava.com or by ringing: 01452 726700.
The BEVA Trust is the Association’s philanthropic arm and in 2015 members decided that it should provide support for voluntary projects to help improve knowledge and welfare.
Since then volunteers have been rolling up their sleeves to help out with castration and welfare clinics in the UK and veterinary training schemes around the world.
Over the past 12 months a total of 42 vets and vet nurses have volunteered their time at seven BHS Education and Welfare Clinics throughout the UK.
They have helped microchip, passport, vaccinate and castrate horses recognised by Welfare Officers as needing help.
So far 598 horses and ponies have received passports and 302 been castrated.
The Trust has seen a further ten volunteers travel across the globe, working on projects in Cambodia, the Gambia, Honduras, Kiev, Nicaragua and the Ukraine.
BEVA President Vicki Nicholls said: "We thank all of the volunteers that make our Trust such a success, with special mention to Luke Edwards from the University of Liverpool and Alice Horne from Ddole Road Veterinary Clinic who have both volunteered at four clinics. We must also remember the good work of our industrious BEVA Council members and our excellent speakers at Congress this September, who are all volunteers."
For further information on BEVA Trust volunteer projects email lara@beva.org.uk to be added to the BEVA Trust mailing list.
The report says the greatest threat to farm animal welfare standards post-Brexit would come from UK farmers competing against cheap, imported food from countries that produce to lower standards than the UK. Therefore, the Government's wish for the UK to become a global leader in free trade is not necessarily compatible with its desire to maintain high animal welfare standards.
Noting the UK's overwhelming reliance on non-UK EU citizens to fill crucial official veterinary positions in the UK, the Committee called on the Government to ensure that the industry is able to retain or recruit qualified staff to fill these roles post-Brexit.
Responding to the report, BVA President Gudrun Ravetz said: "The report offers strong leadership and a clear message, emphasising the consumer and cross-sector consensus that current animal health and welfare standards must be at least maintained in Brexit negotiations. Prioritising these standards in trade negotiations could guarantee a unique selling point for the UK. As the report recommends, as consumers we must make sure we do not compromise quality for cost-savings in order to avoid a race to the bottom for welfare standards. We now need clarity from the Government on how underpinning processes and overarching principles, like Article 13 which ensures animal welfare requirements are fully considered in policy-setting, will be incorporated into domestic law.
"The report supports our view that animal welfare should be considered a public good and we reiterate our calls following the Secretary of State’s recent speech that a replacement CAP scheme should encompass animal welfare, animal health, disease surveillance, biodiversity and environmental stewardship to benefit not only UK producers, but consumers and wider society too.
"The EU Committee’s recognition of the vital role vets play in animal health, welfare and public health is extremely encouraging. Official Veterinarians (OVs) working in abattoirs protect and reassure UK consumers, certifying and supervising the import and export of animals and animal products to third countries. As I outlined in my evidence to the Committee, some estimates suggest 95% of OVs working in UK abattoirs graduated overseas, mostly in the EU. However, we are already hearing of fewer applicants for veterinary public health roles since the referendum.
"There are significant concerns about the potential impact of a post-Brexit veterinary workforce shortage on the UK's £100 billion agri-food sector, in terms of risking business and consumer confidence as well as the UK’s future export capability. A strong, sustainable veterinary workforce is absolutely vital to safeguarding animal health, welfare and public health post Brexit."
Ian (pictured right) qualified from Glasgow University and has a master’s degree in veterinary parasitology. He is head of ESCCAP - the European Scientific Counsel Companion Animal Parasites (ESCCAP) UK and Ireland, guideline director for ESCCAP Europe and editorial board member for Companion Animal. and VetCPD Journal. He is also a practising vet and co-owner of The Mount Veterinary Practice in Fleetwood, Lancashire.
Lockdown has seen a rise in the numbers of dogs and cats in the UK, including imported pets. Horiba says some of these are coming in via the official route, which includes preventative measures to reduce health risks. However, many are moved outside of UK regulations and some will become ill in the days or even months after they arrive. Ian will explain how timely, accurate testing will help detect the threat to these animals.
Lisa Martin from Horiba said: "I hope that as many veterinary surgeons, nurses, students and support staff as possible will join us for our Educational Premiere! We are looking forward to this first webinar in our veterinary CPD series, with expert Ian Wright highlighting the best ways to keep pets and people safe. Join us on 1st July at 7.30pm to hear more and to ask Ian your questions on this very topical subject. Dress code: casual."
To register, visit: https://attendee.gotowebinar.com/register/5429203015286962191
Annual renewal fees for veterinary surgeons will remain at the same level as in 2021: £364 for UK-practising members, £182 for members practising outside the UK and £60 for non-practising members.
The removal of the alternative fee payment arrangements means there will no longer be the option to pay in instalments and the fee needs to be paid in full by the usual deadline of 1 April.
RCVS Treasurer Niall Connell said: “We understand that many veterinary surgeons and veterinary nurses will have been impacted financially over the last couple of years, and we appreciate that this has been a very difficult time for the professions.
"We are pleased that we are able to keep fees static for a second year running, whilst maintaining a strong programme of strategic projects that help to set, uphold and advance standards within the professions.”
The new pass offers both physical and virtual tickets so that the practice rota doesn't have to stop any member of the team from attending.
BEVA says the new tickets also offer a saving of up to £113 per vet.
David Mountford, Chief Executive of BEVA said: “We know that not every vet at a practice can attend congress every year because someone is always going to have to stay behind and work.
"So, by offering a mix of physical and virtual tickets in the pass it means those staying at home to look after the practice can still benefit from the live stream as well as the six-month access to all the lectures afterwards.
"Congress always contains plenty of relevant and dedicated content for nurses, so the pass obviously includes nurse tickets too.”
Practice Passes are available for BEVA members in three packages: small (£599), medium (£1,333) and large (£2,666).
Individual early bird BEVA member prices are £499 for vets and £187 for vet nurses for all three days (with concessions available for those in their first three years’ post-graduation or on a lower salary).
Practice Passes and early bird tickets are available to purchase until Monday 1 August 2022.
Day tickets are also available.
Virtual tickets are £199 for vets and £40 for nurses.
For more information, or to book tickets, visit http://www.bevacongress.org
Ceva Animal Health has highlighted a new study which revealed that the use of the opioid buprenorphine, the active ingredient in Vetergesic, before equine elective general anaesthesia and surgery resulted in better post-operative analgesia than butorphanol, without causing further physiological disruption than is normally expected of general anaesthesia in horses.
The prospective, randomised and blinded multicentre study, conducted by Dr Polly Taylor VetMB MA PhD DVA DipECVAA MRCA MRCVS, an RCVS Specialist in Veterinary Anaesthesia, compared the degree of post-operative pain and physiological variables in horses following premedication with either buprenorphine or butorphanol in a general clinical setting. The study included 89 healthy adult horses from six UK equine veterinary clinics admitted for routine elective surgical procedures.
Ceva says that butorphanol is often used in equine procedures due to familiarity and its value for enhancing alpha2-induced sedation, but that it is probably the least effective opioid as an analgesic. There is also a common perception that butorphanol has less impact on locomotor stimulation and depression of intestinal motility than other opioids. This is likely to have contributed to the almost exclusive use of NSAIDs to manage pain in the post-operative period.
To view the full study, visit http://onlinelibrary.wiley.com/doi/10.1111/evj.12442/abstract. For details on Ceva's analgesic product range, email analgesics-group@ceva.com or call 01494 781510.
The survey is conducted every four to five years and asks vets to answer questions about a variety of subjects including demographic data (for example, socio-economic background, educational attainment, race/ethnicity, disability), work-related data (for example, employment status, location of workplace, type of workplace, hours of work, position in practice) and information about professional achievement (for example, hours of continuing professional development (CPD) undertaken and extra qualifications earned).
The survey, which is conducted on the College’s behalf by the Institute for Employment Studies, also ask respondents about their views on different aspects of their profession, including career plans, challenges facing the profession, and wellbeing.
This year, the survey also asks for your view of the RCVS, including its values, how it should communicate, and what it should prioritise in future years.
Lizzie Lockett, RCVS CEO (pictured right), said: "The results of the Surveys form a very important ‘snapshot’ of the profession at a given point in time, but they also prove useful for years to come in terms of how the College develops its regulatory and educational policy, the areas it chooses to focus on and the issues it chooses to tackle.
"The ensuing reports are also used by a myriad of other individuals, such as those in academia, government and representative bodies, as well as journalists. It’s therefore really important that we have as accurate a picture as possible. So although completing the Surveys is entirely voluntary, we strongly encourage members of the professions to take the time to complete them. It will, ultimately, help the development of appropriate and supportive policies for your profession."
In addition to the main survey, there will be an additional survey for MsRCVS who practise overseas. This survey aims to better understand why they continue to retain their MRCVS status, what this status means in the countries in which they work, global attitudes towards the RCVS and how the College could improve its communication with them.
Vets Now says that the move to holding the 4 day congress online has resulted in a surge in interest from international delegates, with veterinary surgeons and nurses from more than 20 countries, including Kuwait, Hong Kong and Australia, due to attend.
Speakers at the event this year include Dan Fletcher, Megan Brashear and Claire Sharp.
Dan Lewis, Vets Now’s national ECC lead, said: “The interactive platform we’re using is cutting edge and it provides so much more than just webinars. There will be live content, an interactive exhibition hall and more opportunities than ever for delegates to network and learn from some of the world’s leading veterinary experts discussing emergency and critical care.
"Our programme this year has been carefully tailored to provide an inclusive learning experience for vets and vet nurses no matter what stage they’re at in their career, from students through to specialists.
"We’ll obviously miss seeing everyone in person, but we’re very excited that we can gather together online for a one-of-a-kind experience.”
Full four-day tickets for delegates range in price from £60 to £175 and ticket-holders will be able to access all the sessions on-demand for up to a month following the event.
Click here to book your place at Vets Now’s ECC Congress. Registrations close on November 1. To book your place, visit: congress.vets-now.com
To claim the free product, visit www.daxocox.co.uk/trial and use the stock selector to pick the dose sizes to suit the patients you think Daxocox could help.
Animalcare Marketing Manager James Beaumont explained: “When you consider that recent data shows that up to 20% of dogs over one year of age could have some form of OA1, the scale of problem becomes clear – as does the threat to the welfare of our canine companions from OA pain.
“Owners already giving Daxocox to their OA-affected pets, have seen first-hand how it can significantly improve their quality of life.
"90% said that their dog’s osteoarthritis improved, with 84% reporting that their dog’s quality of life improved from “poor or fair” to “good, very good or excellent.”2
James added: “In a study carried out by Animalare, 88% of owners said that weekly NSAID dosing would be easier to remember, or mean they were less likely to miss a dose or that it would control their dog’s pain more effectively.3
“Used as a first line treatment for OA, Daxocox can provide a solid foundation to long-term pain management that suits vets, dogs and their owners.
"As such, we’re confident that once practices have tried it, it will become their canine OA NSAID of choice.”
For more information, visit www.daxocox.co.uk
References
For the randomised controlled trial, 528 dairy heifers were monitored for 34 months to investigate the effects of routine treatment with a NSAID at calving and during treatment for lameness, on the future probability of lameness and culling.
The cows were exposed to normal farm conditions and were split into four groups:
During the study, the probability of lameness was assessed by a lameness outcome score collected every 14 days.
Data on culling was also extracted from farm records.
438 animals were included in the final analysis which revealed that treating a cohort of cows following the group three protocol led to an absolute reduction in lameness of approximately 10% and severe lameness of 3%, compared with animals treated in accordance with conventional best practice (group one).
James Wilson BSc(Hons) PhD, foot health consultant and lead researcher on the trial, said: “It appears that through giving heifers a NSAID at critical time points, we have imparted a substantial, long-lasting benefit to them.
"When freshly calved heifers enter the herd for the first time, we understand that they are (typically) naïve to lameness and have good hoof health.
"By utilising NSAIDs strategically, we believe that we have preserved the functionality of the foot, thereby reducing the risk of lameness.
"This is a highly efficacious, cost-effective means of managing lameness on farm.”
Herd Health Consultancy says that in dairy cows, it is advisable to consider using a zero milk-withhold NSAID which is fully licensed to treat lameness in cattle to avoid any need to discard milk, however no NSAID is currently licensed in the UK to treat the pain associated with calving, so careful advice should be given to farmers based on the farm type and production methods.
https://doi.org/10.3168/jds.2021-21329
Reference
MI:RNA says that current testing practices for Johne’s disease mean that identification of the disease is difficult, with current sensitivities of around 10-40% and little to no ability to diagnose early stages of infection.
The loss of productivity due to Johne’s to the UK agricultural economy is estimated to be in excess of £10 million annually.
MI:RNA says it is the first diagnostic testing company to use microRNA assay technology.
MicroRNAs are newly discovered biomarkers that manage the immune system and immune responses and act as regulators for disease progression or resolution.
This, says the company, makes them excellent biomarkers of disease, and when combined AI, can significantly improve identification of Johne’s and other complex conditions, and predict disease outcomes.
MI:RNA says this development will allow veterinary surgeons, farmers and pet owners to test for a variety of conditions, not just Johne’s.
Target areas include heart and kidney disease, osteoarthritis and bovine tuberculosis, along with effective general wellness and preoperative screening.
Eve Hanks, founder and CEO of MI:RNA, said: “Increasing market and global pressures on bovine protein production means that animal health has never been more important.
"This is a key area of research and development for MI:RNA and biomarker science combined with our unique AI-powered modelling, means that we can significantly improve animal health and reduce greenhouse gas output.
“The breakthrough that we’ve already achieved in Johne’s testing is unparalleled, and has provided an opportunity for MI:RNA to pitch our business concept in the USA to the The Kansas City Animal Health Summit.
"Following our presentation, we have now progressed through to the final selection stage for European Innovation Council funding for our work on Johne’s disease.
“In terms of future applications, microRNAs can assist with vital drug discovery, progressing future diagnostic testing and understanding disease pathways more effectively.
"We’ve already made remarkable progress and we know that with the continued backing of our tech, AI and health experts and with the correct funding, that we can do so much more.”
Mr Bowles faced four charges, but did not respond to the College's notification about the hearing, so the Committee decided to proceed in his absence.
The first charge was that in 2020, while attending a farm in Lincolnshire in his capacity as an Official Veterinarian (OV), Mr Bowles carried out Intradermal Comparative Tuberculin (ICT) tests on a herd of cattle but failed to measure the skin thickness of all the cattle using callipers and failed to take and record measurements for the cattle.
The Committee was provided with evidence that Mr Bowles had, in earlier correspondence with the College, admitted that he had failed to follow Animal and Plant Health Agency (APHA) standard operating procedures for ICT testing at the farm and so the charge was found proven.
The second charge was that he then certified the results of the inaccurate ICT test he'd performed earlier.
The Committee found this charge proven on the basis that, without using callipers to measure skin thickness, he was not entitled to certify the test.
The third charge was that his conduct in relation to the first two charges was dishonest, misleading and risked undermining government testing procedures designed to promote public health and animal welfare.
The Committee found all elements of the charges proven.
The final charge was that Mr Bowles's conduct took place despite warnings, advice and re-training being given by the APHA.
These included: a letter sent to Mr Bowles’s by APHA in 2014 about the suspension of his OV status after he failed to comply with APHA rules; a letter sent by the APHA to Mr Bowles’s employer in October 2016 regarding issues of non-compliance it had found during a September 2016 audit; and the suspension of Mr Bowles’s OV duties by his employer, pending further training, following issues of non-compliance.
Given Mr Bowles’s history of non-compliance with APHA standard operating procedures and standards, the Committee found the charge proven.
The Committee found that charges 1 to 3 amounted to serious professional misconduct but that charge 4, while making the conduct in the other charges more serious, did not in and of itself constitute serious professional misconduct.
In determining the most appropriate sanction for Mr Bowles, the Committee found that he had paid ‘scant regard’ to the testing procedures set out by APHA and breached the RCVS certification requirements set out in the Code of Professional Conduct for Veterinary Surgeons in ‘numerous and serious’ ways.
Hilary Lloyd, chairing the Committee and speaking on its behalf, said: “The Committee’s view is that the respondent’s conduct in refusing to follow the OV Instructions when testing cattle in May 2020 constituted conduct of an egregious kind.
"In addition, there are several aggravating elements which can be applied to his misconduct, including a risk to animal or human health; his lack of probity and integrity in certifying test results which he knew were non-compliant and unreliable; recklessness in reaching a conscious decision to ignore the OV Instructions; his failure to comply with the requirements of the position of trust and responsibility which attached to his APHA authorisation; and against a backdrop of sustained pattern of behaviour that displayed blatant disregard of the system that regulated TB testing by OVs.
"It follows that the respondent manifested no insight into the seriousness of his misconduct when acting as an OV.”
The Committee considered whether there were any mitigating factors regarding Mr Bowles’ conduct.
It took into account that Mr Bowles had not secured any financial advantage, that there was no actual harm to animals, and that he had a long career as a veterinary surgeon, although with a history of non-compliance.
It noted that there had been some late admissions of misconduct by Mr Bowles when he tendered an apology, but found this mitigation was undermined by the fact his explanations lacked consistency and that he had also initially asserted that he had used callipers during the testing.
Due to the seriousness of the non-compliance, the dishonesty and the potential risk to public health, the Committee considered that removing Mr Bowles from the Register was the only proportionate and appropriate response to the scale of misconduct.
Hilary added: “Given the amount of advice received and re-training which the respondent was required to undertake, he has already had ample opportunity to remediate his practice but has not done so.
"The Committee is therefore concerned that there is a very real risk of further repetition of this conduct in the future were he to be permitted to remain on the Register.
“The Committee’s concern in this regard stems from the fact that the dishonesty of which the respondent has been found guilty, was not dishonesty committed on the spur of the moment.
"The respondent had ample opportunities for reflection before resolving to act as he did.
"This places his acts of dishonesty in the most serious category.
“The public is entitled to expect that it can have confidence in the certifications of a veterinary surgeon who is carrying out a public duty on behalf of that public body.
"Indeed, that is the whole purpose behind the requirement that OVs undertake additional and specialised training before being permitted to undertake OV duties.”
www.rcvs.org.uk/disciplinary
The Company of Animals, makers of behaviour and training products, has announced the launch of a new Product and Training DVD, designed to be screened in practice waiting rooms. The DVD features the entire range of products from Company of Animals, including its multi-award-winning dog training devices, being demonstrated by pet dogs and their owners. It is presented by Animal Psychologist and founder of The Company of Animals, Dr. Roger Mugford. The Company of Animals says that playing the DVD during opening hours will grab the attention of your customers, raise their awareness of already popular products, and educate them about new ones. This DVD is free and available to all veterinary retailers. To order the DVD or for more information see: http://www.companyofanimals.co.uk/
Her Royal Highness Princess Anne has opened the Royal Veterinary College's new Teaching and Research Centre.
The Centre - at the college's Hawkshead Campus in Potters Bar, Hertfordshire - will provide a home for the RVC's lifestyle research, which includes conditions such as obesity/diabetes, chronic kidney disease and arthritis as well as those with genetic roots.
RVC Principal Professor Stuart Reid said: "The RVC is extremely proud to have welcomed Her Royal Highness to open the new Teaching and Research Centre - a facility where our students are taught within an environment that is all about advanced scientific discovery and first class research. The building houses the engine of academic enquiry and is a wonderful space where our academic community generates new insights into diseases that affect humans and animals.
"The Centre allows us to tie together the various threads we have around the study of illnesses that result from lifestyle in humans and animals, such as those associated with age or genetic disorders. Our College collaborates with the research hub that is the London scientific research community. We are extremely well placed to carry out the work in conjunction with human medical research groups and bring the veterinary perspective to the understanding of disease. The building offers new opportunities, both nationally and internationally".
Funding for the building of the new centre was provided by HEFCE and The Wolfson Foundation.
Photo: Paul West
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.
In the last four years, there has been an increase in the number of identified B. canis cases in the UK, which had previously been sporadic and isolated.
Data released by the Government shows that cases have risen from three reported before 2020 to 240 in the last three years.
Most dogs were either imported, had returned from holiday overseas, or been bred with an imported dog.
In 2022, the first UK case of dog-to-human transmission was reported, highlighting the risks to those handling and treating infected dogs and raising levels of concern within veterinary teams, although the BVA says the risk is relatively low.
The BVA, SPVS and BVNA joint policy calls on the Government to :
British Veterinary Association President Anna Judson said: “Vets are seriously concerned about the lack of adequate checks for potentially zoonotic diseases entering the country via imported dogs.
"Brucella canis is not currently considered to be widespread in the UK, so a proactive approach with an emphasis on reducing the risk of this and other worrying exotic diseases being brought into the UK is crucial.
“This is important both for the health of the UK’s dogs and the humans who care for them."
https://www.bva.co.uk/take-action/our-policies/brucella-canis
Police have advised veterinary practices to be on their guard following a spate of break-ins in the South East, linked to the theft of controlled drugs.
PC Steve Doswell, Controlled Drugs Liaison Officer in the East Sussex police area said: "Criminal elements in the South East are targeting practices in Surrey, Hampshire and East Sussex. They may well have targeted, or will target, other practices in all of the neighbouring counties".
"Methadone, Ketamine, Alprazolam and Diazepam are all commonly-abused by drug users, and nationally there have been a lot of problems with users buying street heroin that has been cut with Alprazolam," he added.
PC Doswell offered the following advice to practices:
More detailed information about the correct storage of controlled drugs can be found in the RCVS Practice Standards Scheme Manual: www.rcvs.org.uk/practicestandards
Novartis Animal Health has announced that Crovect 1.25% Pour-On solution for sheep, a broad spectrum ectoparasiticide, is now licenced for the treatment of ticks, with a persistent efficacy of ten weeks and the majority killed within three hours.
Crovect also works in the treatment and control of headflies, the treatment of biting lice, and the prevention and treatment of blowfly strike in sheep.
Crovect has a meat withhold period of eight days. Novartis says this makes Crovect the long-lasting tick treatment with the shortest meat withhold period available, which is of use to farmers taking lambs to market at this time of year.
Helen Langham, Brand Manager at Novartis Animal Health said: "Farmers now have another option available for effective and long lasting tick treatment for their flocks, and one that can be flexibly used in lambs to be marketed. This should greatly reduce the worry of tick infestation along with the associated welfare and economic problems, and we are pleased to bring this solution to the market".
The RCVS has announced that voting is now open for the 2016 Council elections.
Ballot papers with candidate details, biographies and manifestos have been posted to all veterinary surgeons this week.
Eight candidates are standing in the RCVS Council election this year, with the six who receive the most votes joining Council at RCVS Day on Friday 15 July 2016 for a four-year term. The candidates are:
Each candidate in both elections has produced a short video in which they answer two questions which they have selected from those submitted to the RCVS in advance by members of the professions. The videos can be viewed at: www.rcvs.org.uk/vetvote16 along with their biographies, manifesto statements and contact details.
Bradley Viner, RCVS President, said: "Last year the candidate videos had over 3,500 views and we hope to increase that this year as it is a very direct and democratic way of finding out more about each candidate and their views. I would urge each member of the profession, whether vets or veterinary nurses, to make a vote for their preferred candidates as they really can make a difference when it comes to the future direction of the College."
All votes must be cast, either online or by post, by 5pm on Friday 29 April 2016. Online votes for RCVS Council candidates can be made at www.ersvotes.com/vetvote16.
Any veterinary surgeon who has not received a ballot paper should contact Ian Holloway, RCVS Communications Manager, on 020 7202 0727 or i.holloway@rcvs.org.uk.
Dan (MRCVS) & Kirsty (RVN) Forster, the husband and wife team behind Isle of Wight-based The Mobile Vet are celebrating a Queen's Award for Enterprise.
The Mobile Vet offers a mobile service in custom-designed vehicles and also has a fully-equipped surgery based in Newport where further consultations, operations and diagnostics can be performed, giving clients the option to choose between a home visit or a more traditional form of veterinary care for their pets.
News of the award landed on their doormat recently, in a letter saying: "I am delighted to inform you that Her Majesty The Queen has been graciously pleased to approve the Prime Minister's recommendation that your organisation should receive a Queen's Award for Enterprise in Innovation this year."
The Queen announced the winners of the awards as part of her 90th birthday celebrations yesterday, and Kirsty & Dan have been invited to Buckingham Palace to meet her at an official reception in July.
Dan said: "We have been fortunate enough to receive excellent feedback from our clients since starting our business & enjoy an immense amount of job satisfaction with the way we work. A nod from Her Majesty is truly the crowning glory for our business. It just goes to show what can be achieved with exceptional hard work and effort, the love & support of family/friends & a formidable staff. This award is for all these people that help to make our business great!
"We are very much looking forward to meeting the Queen and can't quite get our heads round it. Kirsty has spent hours looking for a dress and I am brushing up on my royal etiquette!"
HRH The Princess Royal has opened the Animal Health Trust's new cancer treatment and research facility in Suffolk.
The facility has been purpose-built to treat horses, dogs and cats with cancer. It will also assist in furthering understanding of the disease in animals.
Peter Webbon, Chief Executive of the AHT, said: "2012 marks 70 years of the AHT fighting disease and injury in animals, and the addition of the Cancer Centre is a landmark achievement in our history. We believe this is the first facility of its kind in Europe, purpose-built to treat horses, dogs and cats with cancer. We now have a short commissioning process to undertake but anticipate welcoming the first patients through the doors in early 2013."
The Kennel Club Cancer Centre at the AHT houses a linear accelerator (pictured right) and brachytherapy machine used in radiotherapy treatment, along with a 16-slice CT scanner to aid radiotherapy planning.
The new facility complements the AHT's existing cancer treatment options of surgery and chemotherapy meaning the Suffolk-based charity will be able to offer each and every patient the very best options for their specific case, whatever the diagnosis. With one in four dogs and one in six cats developing cancer at some time in their life the new centre will help many more animals fight cancer.
Peter Webbon, added: "It was thanks to a generous donation from the late Tom Scott, a long-term supporter of the AHT, that we were able to start this development. His donation, along with that from many other AHT supporters, and an interest-free loan of £1.5 million from the Kennel Club has meant this ambitious project has come to fruition so quickly."
It has taken just over a year to build the Cancer Centre which contains more than 2,600 tonnes of concrete and has eight-feet wide solid concrete walls.
On opening the facility, HRH The Princess Royal, President of the AHT, said: "This Cancer Centre is an exciting development at the AHT and will make a real difference for animals with cancer, here and now. It will improve the chances, for many animals, of beating this pernicious disease.
"Countless other horses, dogs and cats across the world with cancer, who will never be seen by an AHT clinician, will also benefit from knowledge gained from research in The Kennel Club Cancer Centre at the AHT."
The AHT has a strong history in cancer research and the Kennel Club Cancer Centre will enhance the charity's well established cancer research programme. Knowledge gained through the treatment of animals in the facility will contribute to the study of cancers, their causes, early diagnosis and treatment, and ultimately hopefully the prevention of some forms of the disease.
Steve Dean, Kennel Club Chairman, said: "I am very proud to be here today to celebrate the opening of the Kennel Club Cancer Centre. Thanks to the expertise available here at the Animal Health Trust, the Cancer Centre will provide advanced techniques for the diagnosis and treatment of cancer, to the benefit of many animals. It is exciting to consider how synergy between the Kennel Club Cancer Centre and the Kennel Club Genetics Centre can help to further the understanding of the inheritance factors that influence the development of cancer."
Nominees for the RCVS Council and its Veterinary Nurses Council have been announced, with 13 candidates for the former and four for the latter.
The nominations closed on 31 January, and the following are standing:
RCVS Council
* denotes current RCVS Council member
VN Council
* denotes current VN Council member